首页> 美国卫生研究院文献>Annals of General Hospital Psychiatry >Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

【2h】

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

机译：帕潘立酮缓释剂与替代口服抗精神病药相比在希腊精神分裂症患者中的成本和效果：一项成本效益研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Correction to Geitona M, Kousoulakou H, Ollandezos M, Athanasakis K, Papanicolaou S and Kyriopoulos I: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study. Annals of General Psychiatry 2008, 7:16. This correction reports changes in the values listed for Ziprasidone and Aripiprazole in Table Ten.

机译：更正Geitona M，Kousoulakou H，Ollandezos M，Athanasakis K，Papanicolaou S和Kyriopoulos I：在希腊精神分裂症患者中，与替代口服抗精神病药相比，帕潘立酮缓释的成本和效果：一项成本效果研究。普通精神病学年鉴2008，7:16。此更正报告了表十中所列齐普西酮和阿立哌唑的值变化。

著录项

期刊名称 Annals of General Hospital Psychiatry
作者
Maria Geitona; Hara Kousoulakou; Markos Ollandezos; Kostas Athanasakis; Sotiria Papanicolaou; Ioannis Kyriopoulos;
展开▼
作者单位

展开▼
年(卷),期 2009(8),-1
年度 2009
页码 15
总页数 2
原文格式 PDF
正文语种
中图分类精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Long-term effectiveness of flexibly dosed paliperidone extended-release: Comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents [J] . KimE.Y., ChangS.M., ShimJ.C., Current medical research and opinion . 2013,第10期

机译：灵活剂量帕潘立酮缓释的长期疗效：从利培酮和其他抗精神病药转换为精神分裂症的患者之间的比较
2. Long-term effectiveness of flexibly dosed paliperidone extended-release: Comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents [J] . KimE.Y., ChangS.M., ShimJ.C., Current medical research and opinion . 2013,第10期

机译：灵活剂量帕潘立酮缓释的长期疗效：从利培酮和其他抗精神病药转换为精神分裂症的患者之间的比较
3. Cost-effectiveness of long-acting risperidone injection versus alternative atypical antipsychotic agents in patients with schizophrenia in China. [J] . Yang L, Li M, Tao LB, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2009,第Suppla3期

机译：长效利培酮注射液与替代性非典型抗精神病药在中国精神分裂症患者中的成本效益。
4. A model for cost effectiveness analysis of using genetic information of oral anticoagulation patients [C] . Archetti F., Giordani I., Messina E., Health Care Management (WHCM), 2010 . 2010

机译：口服抗凝患者遗传信息的成本效益分析模型
5. Cost-Effectiveness of Oral Agents in Relapsing-Remitting Multiple Sclerosis Compared to Interferon-Based Therapy in Saudi Arabia [D] . Alskaabi, May. 2017

机译：沙特阿拉伯口服药物在复发缓解型多发性硬化症中的成本效果与基于干扰素的疗法相比
6. Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study [O] . Maria Geitona, Hara Kousoulakou, Markos Ollandezos, 2008

机译：帕潘立酮缓释剂与替代口服抗精神病药相比在希腊精神分裂症患者中的成本和效果：一项成本效益研究
7. Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study [O] . Papanicolaou Sotiria, Athanasakis Kostas, Ollandezos Markos, 2009

机译：帕潘立酮缓释剂与替代口服抗精神病药相比在希腊精神分裂症患者中的成本和效果：一项成本效益研究
8. Retrospective Study Comparing the Costs and Outcomes of Three Alternatives for Monitoring Patients Who Come to an Emergency Department with Chest Pain (ICD-9 Code 78650 and 78659) [R] . Borgfeld, J. K. 2000

机译：回顾性研究比较三种替代方案的成本和结果，用于监测患有胸痛的急诊科患者（ICD-9代码78650和78659）

Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study

摘要

著录项

相似文献

相关主题

期刊订阅